Publications 2025

Alroughani R, Celius EG, Gray H, Kasilingam E, Kruger P, Montague A, Oreja-Guevara C, Plant A, Pontaga M, Rieckmann P, Ritter L, Sumelahti ML (2025)
Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group
(in press)
DOI 10.1007/s40120-025-00849-0, PubMed 41191274

Bogale B, Solem IKL, Larsen AG, Celius EG, Halvorsrud R (2025)
Patient Pathways Inefficiencies in Neurology Care: Providers' Perspectives
329, 1676-1677
DOI 10.3233/SHTI251159, PubMed 40776176

Cortese R, Sforazzini F, Gentile G, de Mauro A, Luchetti L, Amato MP, Apóstolos-Pereira SL, Arrambide G, Bellenberg B, Bianchi A, Bisecco A, Bodini B, Calabrese M, Camera V, Celius EG, de Medeiros Rimkus C, Duan Y, Durand-Dubief F, Filippi M, Gallo A, Gasperini C, Granziera C, Groppa S, Grothe M, Gueye M et al. (2025)
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease
105 (6), e214075
DOI 10.1212/WNL.0000000000214075, PubMed 40906978

Høgestøl EA, Rinker DA, Maximov I, Sowa P, Celius EG, Hope TR, Bjørnerud A, Sofia FM, de Las Heras EM, Solana E, Llufriu S, Gamez JFC, Farre JA, Pareto D, Collorone S, Pagani E, Gonzalez-Escamilla G, Groppa S, Sastre-Garriga J, Rovira À, Toosy A, Filippi M, Rocca MA, Westlye LT, Harbo HF et al. (2025)
A cross-sectional multicentre study of multishell diffusion MRI in multiple sclerosis
98, 106435
DOI 10.1016/j.msard.2025.106435, PubMed 40233645

Simonsen CS, Flemmen HØ, Broch L, Brekke K, Myklebust H, Berg-Hansen P, Brunborg C, Celius EG (2025)
Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort study
31 (4), 398-407
DOI 10.1177/13524585251315077, PubMed 39957514

Simonsen CS, Moen MH, Celius EG (2025)
Lower threshold for hormone therapy in women with multiple sclerosis
145
DOI 10.4045/tidsskr.25.0070, PubMed 40272242

Skattebøl L, Lundby R, Øverås MH, Sowa P, Celius EG, Harbo HF, Nordhøy W, Høgestøl EA, Nygaard GO (2025)
Quantitative susceptibility mapping of paramagnetic rim lesions in early multiple sclerosis: A cross-sectional study of brain age and disability
5 (3), 100277
DOI 10.1016/j.ynirp.2025.100277, PubMed 41050950

Skattebøl L, Nygaard GO, Leonardsen EH, Kaufmann T, Moridi T, Stawiarz L, Ouellette R, Ineichen BV, Ferreira D, Muehlboeck JS, Beyer MK, Sowa P, Manouchehrinia A, Westman E, Olsson T, Celius EG, Hillert J, Kockum I, Harbo HF, Piehl F, Granberg T, Westlye LT, Høgestøl EA (2025)
Brain age in multiple sclerosis: a study with deep learning and traditional machine learning
7 (3), fcaf152
DOI 10.1093/braincomms/fcaf152, PubMed 40337466

Publications 2024

Bogale B, Vesinurm M, Lillrank P, Celius EG, Halvorsrud R (2024)
Visual Modeling Languages in Patient Pathways: Scoping Review
13, e55865
DOI 10.2196/55865, PubMed 39546800

Cortese R, Battaglini M, Prados F, Gentile G, Luchetti L, Bianchi A, Haider L, Jacob A, Palace J, Messina S, Paul F, Marignier R, Durand-Dubief F, de Medeiros Rimkus C, Apostolos Pereira SL, Sato DK, Filippi M, Rocca MA, Cacciaguerra L, Rovira À, Sastre-Garriga J, Arrambide G, Liu Y, Duan Y, Gasperini C et al. (2024)
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
96 (2), 276-288
DOI 10.1002/ana.26951, PubMed 38780377

Prosperini L, Arrambide G, Celius EG, Goletti D, Killestein J, Kos D, Lavorgna L, Louapre C, Sormani MP, Stastna D, Ziemssen T, Di Filippo M (2024)
COVID-19 and multiple sclerosis: challenges and lessons for patient care
44, 100979
DOI 10.1016/j.lanepe.2024.100979, PubMed 39429966

Simonsen CS, Flemmen HØ, Broch L, Myklebust H, Berg-Hansen P, Brunborg C, Celius EG (2024)
The influence of menopause on multiple sclerosis
32 (1), e16566
DOI 10.1111/ene.16566, PubMed 39601490

Publications 2023

Berg-Hansen P, Moen SM, Klyve TD, Gonzalez V, Seeberg TM, Celius EG, Austeng A, Meyer F (2023)
The instrumented single leg stance test detects early balance impairment in people with multiple sclerosis
14, 1227374
DOI 10.3389/fneur.2023.1227374, PubMed 37538255

Broch L, Flemmen HØ, Simonsen CS, Berg-Hansen P, Ormstad H, Brunborg C, Celius EG (2023)
"No association between disease modifying treatment and fatigue in multiple sclerosis"
79, 104993
DOI 10.1016/j.msard.2023.104993, PubMed 37708819

Cortese R, Battaglini M, Prados F, Bianchi A, Haider L, Jacob A, Palace J, Messina S, Paul F, Wuerfel J, Marignier R, Durand-Dubief F, de Medeiros Rimkus C, Callegaro D, Sato DK, Filippi M, Rocca MA, Cacciaguerra L, Rovira A, Sastre-Garriga J, Arrambide G, Liu Y, Duan Y, Gasperini C, Tortorella C et al. (2023)
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults
146 (6), 2489-2501
DOI 10.1093/brain/awac480, PubMed 36515653

Wolf AS, Ravussin A, König M, Øverås MH, Solum G, Kjønstad IF, Chopra A, Holmøy T, Harbo HF, Syversen SW, Jørgensen KK, Høgestøl EA, Vaage JT, Celius EG, Lund-Johansen F, Munthe LA, Nygaard GO, Mjaaland S (2023)
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
8 (12)
DOI 10.1172/jci.insight.165111, PubMed 37159281

Publications 2022

Berg-Hansen P, Moen SM, Austeng A, Gonzales V, Klyve TD, Negård H, Seeberg TM, Celius EG, Meyer F (2022)
Sensor-based gait analyses of the six-minute walk test identify qualitative improvement in gait parameters of people with multiple sclerosis after rehabilitation
269 (7), 3723-3734
DOI 10.1007/s00415-022-10998-z, PubMed 35166925

Broch L, Flemmen HØ, Simonsen CS, Berg-Hansen P, Ormstad H, Brunborg C, Celius EG (2022)
Fatigue in multiple sclerosis is associated with socioeconomic factors
64, 103955
DOI 10.1016/j.msard.2022.103955, PubMed 35753177

Drobnjak Nes D, Berg-Hansen P, de Rodez Benavent SA, Høgestøl EA, Beyer MK, Rinker DA, Veiby N, Karabeg M, Petrovski BÉ, Celius EG, Harbo HF, Petrovski G (2022)
Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis
11 (11)
DOI 10.3390/jcm11113109, PubMed 35683496

Eid K, Torkildsen Ø, Aarseth J, Celius EG, Cortese M, Holmøy T, Kapali A, Myhr KM, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH (2022)
Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
269 (11), 5901-5909
DOI 10.1007/s00415-022-11249-x, PubMed 35780399

Eid K, Torkildsen Ø, Aarseth J, Aalstad M, Bhan A, Celius EG, Cortese M, Daltveit AK, Holmøy T, Myhr KM, Riise T, Schüler S, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH (2022)
Association of adverse childhood experiences with the development of multiple sclerosis
93 (6), 645-650
DOI 10.1136/jnnp-2021-328700, PubMed 35379699

Flemmen HØ, Simonsen CS, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Kersten H, Celius EG (2022)
The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort
61, 103759
DOI 10.1016/j.msard.2022.103759, PubMed 35358792

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Midgard R, Vatne A, Aarseth JH, Mannseth J, Torkildsen Ø (2022)
Cancer related mortality in multiple sclerosis. A population based cohort study
69, 104417
DOI 10.1016/j.msard.2022.104417, PubMed 36423459

Leonardsen EH, Peng H, Kaufmann T, Agartz I, Andreassen OA, Celius EG, Espeseth T, Harbo HF, Høgestøl EA, Lange AM, Marquand AF, Vidal-Piñeiro D, Roe JM, Selbæk G, Sørensen Ø, Smith SM, Westlye LT, Wolfers T, Wang Y (2022)
Deep neural networks learn general and clinically relevant representations of the ageing brain
256, 119210
DOI 10.1016/j.neuroimage.2022.119210, PubMed 35462035

Nygaard GO, Torgauten H, Skattebøl L, Høgestøl EA, Sowa P, Myhr KM, Torkildsen Ø, Celius EG (2022)
Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis
62, 103812
DOI 10.1016/j.msard.2022.103812, PubMed 35462167

Oreja-Guevara C, Brownlee W, Celius EG, Centonze D, Giovannoni G, Hodgkinson S, Kleinschnitz C, Havrdova EK, Magyari M, Selchen D, Vermersch P, Wiendl H, Van Wijmeersch B, Salloukh H, Yamout B (2022)
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
69, 104459
DOI 10.1016/j.msard.2022.104459, PubMed 36565573

Simonsen CS, Flemmen HØ, Broch L, Brekke K, Brunborg C, Berg-Hansen P, Celius EG (2022)
Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population
13, 1034056
DOI 10.3389/fneur.2022.1034056, PubMed 36452173

Publications 2021

Broch L, Simonsen CS, Flemmen HØ, Berg-Hansen P, Skardhamar Å, Ormstad H, Celius EG (2021)
High prevalence of fatigue in contemporary patients with multiple sclerosis
7 (1), 2055217321999826
DOI 10.1177/2055217321999826, PubMed 33796331

Celius EG, Thompson H, Pontaga M, Langdon D, Laroni A, Potra S, Bharadia T, Yeandle D, Shanahan J, van Galen P, Alexandri N, Kesselring J (2021)
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
15, 15-27
DOI 10.2147/PPA.S268829, PubMed 33447018

Flemmen HØ, Simonsen CS, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Kersten H, Celius EG (2021)
Maternal education has significant influence on progression in multiple sclerosis
53, 103052
DOI 10.1016/j.msard.2021.103052, PubMed 34111658

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman MT, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø (2021)
Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study
55, 103209
DOI 10.1016/j.msard.2021.103209, PubMed 34419754

Hammerstad SS, Celius EG, Husby H, Sørensen IM, Norheim IE (2021)
Management of Severe Graves' Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis
5 (6), bvab044
DOI 10.1210/jendso/bvab044, PubMed 34017934

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
94 (1), 19-22
DOI 10.1136/jnnp-2021-327612, PubMed 34670844

Saposnik G, Andhavarapu S, Fernández Ó, Kim HJ, Wiendl H, Foss M, Zuo F, Havrdová EK, Celius E, Caceres F, Magyari M, Bermel R, Costa A, Terzaghi M, Kalincik T, Popescu V, Amato MP, Montalban X, Oh J (2021)
Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study
58, 103404
DOI 10.1016/j.msard.2021.103404, PubMed 35216786

Saposnik G, Andhavarapu S, Fernández Ó, Kim HJ, Wiendl H, Foss M, Zuo F, Havrdová EK, Celius EG, Caceres F, Magyari M, Bermel R, Costa A, Terzaghi M, Kalincik T, Popescu V, Amato MP, Montalban X, Oh J (2021)
Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists
57, 103389
DOI 10.1016/j.msard.2021.103389, PubMed 35158479

Simonsen CS, Flemmen HØ, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2021)
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
12, 693017
DOI 10.3389/fneur.2021.693017, PubMed 34220694

Simonsen CS, Flemmen HØ, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2021)
No significant differences in absenteeism or academic achievements in a Norwegian multiple sclerosis case control study
54, 103141
DOI 10.1016/j.msard.2021.103141, PubMed 34273610

Publications 2020

Bertolotto A, Arroyo R, Celius EG, Comi G, Havrdova EK, Honeycutt WD, Hunter SF, Izquierdo G, Kornek B, Miller T, Mitsikostas DD, Singer BA, Ziemssen T, Chung L, Daizadeh N, Afsar S, Hashemi L, Senior P (2020)
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies
9 (2), 443-457
DOI 10.1007/s40120-020-00191-7, PubMed 32410147

Brorson IS, Eriksson AM, Leikfoss IS, Vitelli V, Celius EG, Lüders T, Berge T, Harbo HF, Nilsen H, Bos SD (2020)
CD8⁺ T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls
6 (4), 2055217320978511
DOI 10.1177/2055217320978511, PubMed 33343920

Celius EG (2020)
Breastfeeding and treatment of multiple sclerosis
27 (5), 801-802
DOI 10.1177/1352458520931786, PubMed 32507035

Celius EG (2020)
Normal antibody response after COVID-19 during treatment with cladribine
46, 102476
DOI 10.1016/j.msard.2020.102476, PubMed 32882501

Elvsåshagen T, Bahrami S, van der Meer D, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Beyer MK, Blasi G, Borgwardt S, Boye B, Buitelaar J, Bøen E, Celius EG, Cervenka S, Conzelmann A, Coynel D, Di Carlo P, Djurovic S, Eisenacher S, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B et al. (2020)
The genetic architecture of human brainstem structures and their involvement in common brain disorders
11 (1), 4016
DOI 10.1038/s41467-020-17376-1, PubMed 32782260

Flemmen HØ, Simonsen CS, Berg-Hansen P, Moen SM, Kersten H, Heldal K, Celius EG (2020)
Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
45, 102352
DOI 10.1016/j.msard.2020.102352, PubMed 32707528

Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Di Carlo P, Djurovic S, Dørum ES et al. (2020)
Publisher Correction: Common brain disorders are associated with heritable patterns of apparent aging of the brain
23 (2), 295
DOI 10.1038/s41593-019-0553-6, PubMed 31848485

Oh J, Achiron A, Celius EG, Chambers C, Derwenskus J, Devonshire V, Hellwig K, Hutton GJ, McCombe P, Moore M, Rog D, Schneider JR, Simm RF, Sousa L, Vincent SG, Chung L, Daizadeh N, Mitchell C, Compston DAS, CAMMS223, CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators (2020)
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years
43, 102146
DOI 10.1016/j.msard.2020.102146, PubMed 32498033

Ormstad H, Simonsen CS, Broch L, Maes DM, Anderson G, Celius EG (2020)
Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways
46, 102533
DOI 10.1016/j.msard.2020.102533, PubMed 33010585

Sá MJ, Soares Dos Reis R, Altintas A, Celius EG, Chien C, Comi G, Graus F, Hillert J, Hobart J, Khan G, Kissani N, Langdon D, Leite MI, Okuda DT, Palace J, Papais-Alvarenga RM, Mendes-Pinto I, Shi FD (2020)
State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis
9 (2), 281-300
DOI 10.1007/s40120-020-00202-7, PubMed 32666470

Simonsen CS, Flemmen HØ, Broch L, Brunborg C, Berg-Hansen P, Moen SM, Celius EG (2020)
The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression
268 (4), 1330-1341
DOI 10.1007/s00415-020-10279-7, PubMed 33090270

Simonsen CS, Flemmen HØ, Lauritzen T, Berg-Hansen P, Moen SM, Celius EG (2020)
The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis
6 (1), 2055217319901291
DOI 10.1177/2055217319901291, PubMed 32030196

Publications 2019

Barclay K, Carruthers R, Traboulsee A, Bass AD, LaGanke C, Bertolotto A, Boster A, Celius EG, de Seze J, Cruz DD, Habek M, Lee JM, Limmroth V, Meuth SG, Oreja-Guevara C, Pagnotta P, Vos C, Ziemssen T, Baker DP, Wijmeersch BV (2019)
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings
10, 253
DOI 10.3389/fneur.2019.00253, PubMed 30967831

Brorson IS, Eriksson A, Leikfoss IS, Celius EG, Berg-Hansen P, Barcellos LF, Berge T, Harbo HF, Bos SD (2019)
No differential gene expression for CD4⁺ T cells of MS patients and healthy controls
5 (2), 2055217319856903
DOI 10.1177/2055217319856903, PubMed 31223483

de Rodez Benavent SA, Nygaard GO, Nilsen KB, Etholm L, Sowa P, Wendel-Haga M, Harbo HF, Drolsum L, Laeng B, Kerty E, Celius EG (2019)
Neurodegenerative Interplay of Cardiovascular Autonomic Dysregulation and the Retina in Early Multiple Sclerosis
10, 507
DOI 10.3389/fneur.2019.00507, PubMed 31156539

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø (2019)
Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study
26 (12), 1569-1580
DOI 10.1177/1352458519877244, PubMed 31573834

Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Di Carlo P, Djurovic S, Dørum ES et al. (2019)
Common brain disorders are associated with heritable patterns of apparent aging of the brain
22 (10), 1617-1623
DOI 10.1038/s41593-019-0471-7, PubMed 31551603

Richter S, Wagner B, Celius EG (2019)
Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease
266 (5), 1270-1271
DOI 10.1007/s00415-019-09257-5, PubMed 30805797

Publications 2018

Celius EG (2018)
[Teaching has low academic status]
138 (12)
DOI 10.4045/tidsskr.18.0341, PubMed 30132612

Celius EG (2018)
Teaching has a low status within academia
Tidsskr. Nor. Laegeforen., 138 (12), 1155

Celius EG, Vila C (2018)
The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity
8 (5), e00962
DOI 10.1002/brb3.962, PubMed 29761015

Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M et al. (2018)
International consensus on quality standards for brain health-focused care in multiple sclerosis
25 (13), 1809-1818
DOI 10.1177/1352458518809326, PubMed 30381987

Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D, James T, Ewing E, Lindén M, Górnikiewicz B, Aeinehband S, Stridh P, Link J, Andlauer TFM, Gasperi C, Wiendl H, Zipp F, Gold R, Tackenberg B, Weber F, Hemmer B, Strauch K, Heilmann-Heimbach S, Rawal R, Schminke U et al. (2018)
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
9 (1), 2397
DOI 10.1038/s41467-018-04732-5, PubMed 29921915

Rhead B, Brorson IS, Berge T, Adams C, Quach H, Moen SM, Berg-Hansen P, Celius EG, Sangurdekar DP, Bronson PG, Lea RA, Burnard S, Maltby VE, Scott RJ, Lechner-Scott J, Harbo HF, Bos SD, Barcellos LF (2018)
Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients
13 (10), e0206511
DOI 10.1371/journal.pone.0206511, PubMed 30379917

Sowa P, Harbo HF, White NS, Celius EG, Bartsch H, Berg-Hansen P, Moen SM, Bjørnerud A, Westlye LT, Andreassen OA, Dale AM, Beyer MK (2018)
Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis
25 (5), 687-698
DOI 10.1177/1352458518765671, PubMed 29542336

Publications 2017

Celius EG (2017)
Infections in patients with multiple sclerosis: Implications for disease-modifying therapy
136 Suppl 201, 34-36
DOI 10.1111/ane.12835, PubMed 29068490

Celius EG, Andersen O, Fredriksen JL (2017)
Preface
136 Suppl 201, 3
DOI 10.1111/ane.12842, PubMed 29068489

de Rodez Benavent SA, Nygaard GO, Harbo HF, Tønnesen S, Sowa P, Landrø NI, Wendel-Haga M, Etholm L, Nilsen KB, Drolsum L, Kerty E, Celius EG, Laeng B (2017)
Fatigue and cognition: Pupillary responses to problem-solving in early multiple sclerosis patients
7 (7), e00717
DOI 10.1002/brb3.717, PubMed 28729927

Olafsson S, Stridh P, Bos SD, Ingason A, Euesden J, Sulem P, Thorleifsson G, Gustafsson O, Johannesson A, Geirsson AJ, Thorsson AV, Sigurgeirsson B, Ludviksson BR, Olafsson E, Kristjansdottir H, Jonasson JG, Olafsson JH, Orvar KB, Benediktsson R, Bjarnason R, Kristjansdottir S, Gislason T, Valdimarsson T, Mikaelsdottir E, Sigurdsson S et al. (2017)
Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations
2, 24
DOI 10.1038/s41525-017-0027-2, PubMed 29263835

Sowa P, Nygaard GO, Bjørnerud A, Celius EG, Harbo HF, Beyer MK (2017)
Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis
59 (7), 655-664
DOI 10.1007/s00234-017-1849-4, PubMed 28585082

Wendel-Haga M, Celius EG (2017)
Is the hygiene hypothesis relevant for the risk of multiple sclerosis?
136 Suppl 201, 26-30
DOI 10.1111/ane.12844, PubMed 29068485

Publications 2016

Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A (2016)
The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
17 (2), 118-27
DOI 10.1038/gene.2015.61, PubMed 26765264

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N (2016)
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study
23 (2), 213-219
DOI 10.1177/1352458516646863, PubMed 27207453

Bos SD, Berge T, Celius EG, Harbo HF (2016)
From genetic associations to functional studies in multiple sclerosis
23 (5), 847-53
DOI 10.1111/ene.12981, PubMed 26948534

Celius EG, Rocca M, Andersen O (2016)
Preface
134 Suppl 200, 3
DOI 10.1111/ane.12653, PubMed 27580898

George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Søndergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BA, Oksenberg JR, Hauser SL et al. (2016)
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
2 (4), e87
DOI 10.1212/NXG.0000000000000087, PubMed 27540591

George MF, Briggs FBS, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedstrom A, Shen L, Bernstein A, Alfredsson L, Hiller J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Sondergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BAC, Oksenberg JR, Hauser SL et al. (2016)
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Neurol.-Genet., 2 (4), eB7
DOI 10.1212/NXG.00000000000000B7

Gustavsen MW, Celius EG, Winsvold BS, Moen SM, Nygaard GO, Berg-Hansen P, Lie BA, Zwart JA, Harbo HF (2016)
Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study
2, 2055217316682976
DOI 10.1177/2055217316682976, PubMed 28607748

Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
S.M. Moen og medarbeidere svarer
136 (19), 1608
DOI 10.4045/tidsskr.16.0826, PubMed 27790879

Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
S.M. Moen og medarbeidere svarer
136 (20), 1702
DOI 10.4045/tidsskr.16.0865, PubMed 27830899

Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK (2016)
[MRI in multiple sclerosis]
136 (16), 1373-6
DOI 10.4045/tidsskr.15.1361, PubMed 27637059

Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK (2016)
MRI- investigations in multiple sclerosis
Tidsskr. Nor. Laegeforen., 136 (16), 1373-1376

Simonsen CS, Celius EG, Brunborg C, Tallaksen C, Eriksen EF, Holmøy T, Moen SM (2016)
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
16 (1), 252
DOI 10.1186/s12883-016-0771-4, PubMed 27919248

Simonsen CS, Edland A, Berg-Hansen P, Celius EG (2016)
High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud
135 (4), 412-418
DOI 10.1111/ane.12615, PubMed 27241360

Publications 2015

Berg-Hansen P, Celius EG (2015)
Socio-economic factors and immigrant population studies of multiple sclerosis
132 (199), 37-41
DOI 10.1111/ane.12429, PubMed 26046557

Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2015)
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'
132 (5), 364-7
DOI 10.1111/ane.12489, PubMed 26423981

Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B et al. (2015)
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
138 (Pt 3), 632-43
DOI 10.1093/brain/awu405, PubMed 25616667

Leikfoss IS, Keshari PK, Gustavsen MW, Bjølgerud A, Brorson IS, Celius EG, Spurkland A, Bos SD, Harbo HF, Berge T (2015)
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells
10 (7), e0132957
DOI 10.1371/journal.pone.0132957, PubMed 26203907

Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A et al. (2015)
Class II HLA interactions modulate genetic risk for multiple sclerosis
47 (10), 1107-1113
DOI 10.1038/ng.3395, PubMed 26343388

Nygaard GO, Celius EG, de Rodez Benavent SA, Sowa P, Gustavsen MW, Fjell AM, Landrø NI, Walhovd KB, Harbo HF (2015)
A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity
10 (8), e0135974
DOI 10.1371/journal.pone.0135974, PubMed 26280173

Nygaard GO, de Rodez Benavent SA, Harbo HF, Laeng B, Sowa P, Damangir S, Bernhard Nilsen K, Etholm L, Tønnesen S, Kerty E, Drolsum L, Inge Landrø N, Celius EG (2015)
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis
4 (6), 585-9
DOI 10.1016/j.msard.2015.08.003, PubMed 26590666

Penner IK, Sivertsdotter EC, Celius EG, Fuchs S, Schreiber K, Berkö S, Svenningsson A, TYNERGY trial investigators (2015)
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness
6, 18
DOI 10.3389/fneur.2015.00018, PubMed 25755648

Sowa P, Bjørnerud A, Nygaard GO, Damangir S, Spulber G, Celius EG, Due-Tønnessen P, Harbo HF, Beyer MK (2015)
Reduced perfusion in white matter lesions in multiple sclerosis
84 (12), 2605-12
DOI 10.1016/j.ejrad.2015.09.007, PubMed 26391230

Publications 2014

Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2014)
High prevalence and no latitude gradient of multiple sclerosis in Norway
20 (13), 1780-2
DOI 10.1177/1352458514525871, PubMed 24603884

Berg-Hansen P, Moen SM, Sandvik L, Harbo HF, Bakken IJ, Stoltenberg C, Celius EG (2014)
Prevalence of multiple sclerosis among immigrants in Norway
21 (6), 695-702
DOI 10.1177/1352458514554055, PubMed 25344371

Gustavsen MW, Celius EG, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Harbo HF (2014)
No association between multiple sclerosis and periodontitis after adjusting for smoking habits
22 (3), 588-90
DOI 10.1111/ene.12520, PubMed 25041906

Gustavsen MW, Page CM, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Celius EG, Harbo HF (2014)
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study
14, 196
DOI 10.1186/s12883-014-0196-x, PubMed 25274070

Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF (2014)
Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general
274 (1-2), 174-9
DOI 10.1016/j.jneuroim.2014.06.024, PubMed 25037176

Lund C, Nakken KO, Edland A, Celius EG (2014)
Multiple sclerosis and seizures: incidence and prevalence over 40 years
130 (6), 368-73
DOI 10.1111/ane.12276, PubMed 25209977

Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF (2014)
Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis
21 (4), 402-14
DOI 10.1177/1352458514543811, PubMed 25139946

Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N (2014)
Month of birth and risk of multiple sclerosis: confounding and adjustments
1 (2), 141-4
DOI 10.1002/acn3.37, PubMed 25356394

Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N (2014)
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
1 (5), 376-7
DOI 10.1002/acn3.56, PubMed 25356407

Trojano M, Celius EG, Donzé C, Izquierdo G, Patti F, Pöhlau D (2014)
Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights
72 Suppl 1, 15-9
DOI 10.1159/000367619, PubMed 25278119

Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J (2014)
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort
23 (5), 688-92
DOI 10.1038/ejhg.2014.155, PubMed 25159868

Publications 2013

Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A (2013)
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis
73 (3), 430-2
DOI 10.1002/ana.23833, PubMed 23444327

Berg-Hansen P, Smestad C, Sandvik L, Harbo HF, Celius EG (2013)
Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway
20 (12), 1546-52
DOI 10.1111/ene.12227, PubMed 23834430

Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA (2013)
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
20 (6), 660-8
DOI 10.1177/1352458513506503, PubMed 24099750

International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M et al. (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
45 (11), 1353-60
DOI 10.1038/ng.2770, PubMed 24076602

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O (2013)
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway
260 (6), 1481-8
DOI 10.1007/s00415-012-6814-x, PubMed 23292231

Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, Kockum I, Oturai AB, Celius EG, Mero IL, Dubois B, Olsson T, Søndergaard HB, Cusi D, Lupoli S, Andreassen BK, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Myhr KM, Guerini FR, PROGEMUS Group, PROGRESSO Group, Comi G, Martinelli-Boneschi F, D'Alfonso S (2013)
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients
8 (6), e64408
DOI 10.1371/journal.pone.0064408, PubMed 23785401

Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH, International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF (2013)
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
8 (3), e58352
DOI 10.1371/journal.pone.0058352, PubMed 23472185

Svenningsson A, Falk E, Celius EG, Fuchs S, Schreiber K, Berkö S, Sun J, Penner IK, Tynergy Trial Investigators (2013)
Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting
8 (3), e58643
DOI 10.1371/journal.pone.0058643, PubMed 23555589

Publications 2012

Brambilla P, Esposito F, Lindstrom E, Sorosina M, Giacalone G, Clarelli F, Rodegher M, Colombo B, Moiola L, Ghezzi A, Capra R, Collimedaglia L, Coniglio G, Celius EG, Galimberti D, Sørensen PS, Martinelli V, Oturai AB, Harbo HF, Hillert J, Comi G, Martinelli-Boneschi F (2012)
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans
530 (2), 155-60
DOI 10.1016/j.neulet.2012.10.008, PubMed 23069673

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT (2012)
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway
19 (8), 1028-34
DOI 10.1177/1352458512471094, PubMed 23257620

Link J, Kockum I, Lorentzen AR, Lie BA, Celius EG, Westerlind H, Schaffer M, Alfredsson L, Olsson T, Brynedal B, Harbo HF, Hillert J (2012)
Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis
7 (5), e36779
DOI 10.1371/journal.pone.0036779, PubMed 22586495

Mero IL, Smestad C, Lie BA, Lorentzen ÅR, Sandvik L, Landrø NI, Aarseth JH, Myhr KM, Celius EG, Harbo HF (2012)
Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course
244 (1-2), 107-10
DOI 10.1016/j.jneuroim.2012.01.011, PubMed 22341604

Moen SM, Celius EG, Sandvik L, Brustad M, Nordsletten L, Eriksen EF, Holmøy T (2012)
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study
7 (9), e45703
DOI 10.1371/journal.pone.0045703, PubMed 23029191

Publications 2011

Hansen B, Oturai AB, Harbo HF, Celius EG, Nissen KK, Laska MJ, Søndergaard HB, Petersen T, Nexø BA (2011)
Genetic association of multiple sclerosis with the marker rs391745 near the endogenous retroviral locus HERV-Fc1: analysis of disease subtypes
6 (10), e26438
DOI 10.1371/journal.pone.0026438, PubMed 22039488

Harbo HF, Lorentzen AR, Lie BA, Celius EG, Spurkland A (2011)
[New gene map for multiple sclerosis]
131 (21), 2126-30
DOI 10.4045/tidsskr.10.0823, PubMed 22048209

Holmøy T, Celius EG (2011)
[Development of new therapies for multiple sclerosis]
131 (8), 832-6
DOI 10.4045/tidsskr.10.0077, PubMed 21556088

International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B et al. (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
476 (7359), 214-9
DOI 10.1038/nature10251, PubMed 21833088

Lundström W, Greiner E, Lundmark F, Westerlind H, Smestad C, Lorentzen AR, Kockum I, Link J, Brynedal B, Celius EG, Harbo HF, Masterman T, Hillert J (2011)
No influence on disease progression of non-HLA susceptibility genes in MS
237 (1-2), 98-100
DOI 10.1016/j.jneuroim.2011.05.003, PubMed 21742385

Moen SM, Celius EG, Nordsletten L, Holmøy T (2011)
Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis
(191), 79-82
DOI 10.1111/j.1600-0404.2011.01548.x, PubMed 21711261

Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holmøy T (2011)
Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome
77 (2), 151-7
DOI 10.1212/WNL.0b013e3182242d34, PubMed 21747073

Reichenbach A, Celius EG, Fure B, Vatn S, Wyller TB (2011)
[Treatment of stroke--an interdisciplinary challenge]
131 (9-10), 934-6
DOI 10.4045/tidsskr.11.0424, PubMed 21606987

Søndergaard HB, Sellebjerg F, Hillert J, Olsson T, Kockum I, Lindén M, Mero IL, Myhr KM, Celius EG, Harbo HF, Christensen JR, Börnsen L, Sørensen PS, Oturai AB (2011)
Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655
19 (10), 1100-3
DOI 10.1038/ejhg.2011.88, PubMed 21610746

Publications 2010

Beyeen AD, Adzemovic MZ, Ockinger J, Stridh P, Becanovic K, Laaksonen H, Lassmann H, Harris RA, Hillert J, Alfredsson L, Celius EG, Harbo HF, Kockum I, Jagodic M, Olsson T (2010)
IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation
185 (11), 6883-90
DOI 10.4049/jimmunol.1001392, PubMed 21041731

Holmøy T, Harbo HF, Celius EG (2010)
[Treatment of multiple sclerosis]
130 (9), 923; author reply 923
DOI 10.4045/tidsskr.10.0346, PubMed 20453948

International Multiple Sclerosis Genetics Consortium (IMSGC), Booth DR, Heard RN, Stewart GJ, Cox M, Scott RJ, Lechner-Scott J, Goris A, Dobosi R, Dubois B, Saarela J, Leppä V, Peltonen L, Pirttila T, Cournu-Rebeix I, Fontaine B, Bergamaschi L, D'Alfonso S, Leone M, Lorentzen AR, Harbo HF, Celius EG, Spurkland A, Link J, Kockum I et al. (2010)
Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis
42 (6), 469-70; author reply 470-1
DOI 10.1038/ng0610-469, PubMed 20502484

Link J, Lorentzen AR, Kockum I, Duvefelt K, Lie BA, Celius EG, Harbo HF, Hillert J, Brynedal B (2010)
Two HLA class I genes independently associated with multiple sclerosis
226 (1-2), 172-6
DOI 10.1016/j.jneuroim.2010.07.006, PubMed 20678810

Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF (2010)
Association to the Glypican-5 gene in multiple sclerosis
226 (1-2), 194-7
DOI 10.1016/j.jneuroim.2010.07.003, PubMed 20692050

Mero IL, Ban M, Lorentzen ÅR, Smestad C, Celius EG, Sæther H, Saeedi H, Viken MK, Skinningsrud B, Undlien DE, Aarseth J, Myhr KM, Granum S, Spurkland A, Sawcer S, Compston A, Lie BA, Harbo HF (2010)
Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus
12 (3), 191-8
DOI 10.1038/gene.2010.59, PubMed 21179112

Ravnborg M, Sørensen PS, Andersson M, Celius EG, Jongen PJ, Elovaara I, Bartholomé E, Constantinescu CS, Beer K, Garde E, Sperling B (2010)
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
9 (7), 672-80
DOI 10.1016/S1474-4422(10)70132-0, PubMed 20542736

Publications 2009

Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, Hawkins C, Robertson NP, Dudbridge F, Wason J, De Jager PL, Hafler D, Rioux JD, Ivinson AJ, McCauley JL, Pericak-Vance M et al. (2009)
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
17 (10), 1309-13
DOI 10.1038/ejhg.2009.41, PubMed 19293837

Celius EG, Smestad C (2009)
Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades
(189), 27-9
DOI 10.1111/j.1600-0404.2009.01208.x, PubMed 19566494

Kemppinen A, Suvela M, Tienari PJ, Elovaara I, Koivisto K, Pirttilä T, Reunanen M, Rautakorpi I, Hillert J, Lundmark F, Oturai A, Ryder L, Harbo HF, Celius EG, Palotie A, Daly M, Peltonen L, Saarela J (2009)
MYO9B polymorphisms in multiple sclerosis
17 (6), 840-3
DOI 10.1038/ejhg.2008.251, PubMed 19142207

Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF (2009)
Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis
65 (6), 658-66
DOI 10.1002/ana.21695, PubMed 19630074

Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, Saarela J, Kemppinen A, Elovaara I, Spurkland A, Dudbridge F, Lie BA, Harbo HF (2009)
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis
18 (4), 502-4
DOI 10.1038/ejhg.2009.195, PubMed 19888296

Ockinger J, Stridh P, Beyeen AD, Lundmark F, Seddighzadeh M, Oturai A, Sørensen PS, Lorentzen AR, Celius EG, Leppä V, Koivisto K, Tienari PJ, Alfredsson L, Padyukov L, Hillert J, Kockum I, Jagodic M, Olsson T (2009)
Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis
11 (2), 142-54
DOI 10.1038/gene.2009.82, PubMed 19865101

Smestad C, Sandvik L, Celius EG (2009)
Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients
15 (11), 1263-70
DOI 10.1177/1352458509107010, PubMed 19812114

Smestad C, Sandvik L, Landrø NI, Celius EG (2009)
Cognitive impairment after three decades of multiple sclerosis
17 (3), 499-505
DOI 10.1111/j.1468-1331.2009.02889.x, PubMed 20050887

Publications 2008

Holmoy T, Celius EG (2008)
Cost-effectiveness of natalizumab in multiple sclerosis
8 (1), 11-21
DOI 10.1586/14737167.8.1.11, PubMed 20528351

Lerdal A, Celius EG, Moum T (2008)
Perceptions of illness and its development in patients with multiple sclerosis: a prospective cohort study
65 (1), 184-92
DOI 10.1111/j.1365-2648.2008.04862.x, PubMed 19032506

Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF (2008)
The SH2D2A gene and susceptibility to multiple sclerosis
197 (2), 152-8
DOI 10.1016/j.jneuroim.2008.04.037, PubMed 18554728

Publications 2007

Celius EG (2007)
Multippel sklerose: er det sykdommen som skal styre livet?
In Pasienten og sykdommen: psykiske faktorer ved somatisk sykdom, Gyldendal akademisk, Oslo, S. 135-141
BIBSYS 071388192

Datta P, Harbo HF, Ryder LP, Akesson E, Benedikz J, Celius EG, Andersen O, Myhr KM, Sandberg-Wollheim M, Hillert J, Svejgaard A, Sorensen PS, Spurkland A, Oturai A (2007)
A follow-up study of Nordic multiple sclerosis candidate gene regions
13 (5), 584-9
DOI 10.1177/1352458506071790, PubMed 17548436

Harbo HF, Utsi E, Lorentzen AR, Kampman MT, Celius EG, Myhr KM, Lie BA, Mellgren SI, Thorsby E (2007)
Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami
69 (4), 299-304
DOI 10.1111/j.1399-0039.2007.00803.x, PubMed 17389012

Hensiek AE, Seaman SR, Barcellos LF, Oturai A, Eraksoi M, Cocco E, Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, Harbo HF, Hauser SL, Heard R, Hillert J, Myhr KM, Marrosu MG, Oksenberg JR, Rajda C, Sawcer SJ, Sørensen PS et al. (2007)
Familial effects on the clinical course of multiple sclerosis
68 (5), 376-83
DOI 10.1212/01.wnl.0000252822.53506.46, PubMed 17261686

Holmøy T, Celius EG (2007)
[Incorrect information about treatment of multiple sclerosis from the Knowledge Center]
127 (12), 1672-3; author reply 1673
PubMed 17571115

Holmøy T, Celius EG (2007)
[A rush job and knowledge handling]
127 (15), 1961-2
PubMed 17700745

Knudsen GP, Harbo HF, Smestad C, Celius EG, Akesson E, Oturai A, Ryder LP, Spurkland A, Ørstavik KH (2007)
X chromosome inactivation in females with multiple sclerosis
14 (12), 1392-6
DOI 10.1111/j.1468-1331.2007.01987.x, PubMed 17970735

Lerdal A, Celius EG, Krupp L, Dahl AA (2007)
A prospective study of patterns of fatigue in multiple sclerosis
14 (12), 1338-43
DOI 10.1111/j.1468-1331.2007.01974.x, PubMed 17903208

Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J (2007)
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis
39 (9), 1108-13
DOI 10.1038/ng2106, PubMed 17660816

Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Masterman T, Akesson E, Spurkland A, Lie BA, Palmgren J, Celius EG, Hillert J, Harbo HF (2007)
The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients
14 (8), 835-40
DOI 10.1111/j.1468-1331.2007.01825.x, PubMed 17662002

Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG (2007)
Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway
255 (1), 49-55
DOI 10.1007/s00415-007-0659-8, PubMed 18080855

Publications 2006

Harbo HF, Ekstrøm PO, Lorentzen AR, Sundvold-Gjerstad V, Celius EG, Sawcer S, Spurkland A (2006)
Coding region polymorphisms in T cell signal transduction genes. Prevalence and association to development of multiple sclerosis
177 (1-2), 40-5
DOI 10.1016/j.jneuroim.2006.04.021, PubMed 16764945

Lundmark F, Harbo HF, Celius EG, Saarela J, Datta P, Oturai A, Lindgren CM, Masterman T, Salter H, Hillert J (2006)
Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations
180 (1-2), 193-8
DOI 10.1016/j.jneuroim.2006.08.009, PubMed 17020785

Publications 2005

Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
166 (1-2), 197-201
DOI 10.1016/j.jneuroim.2005.06.002, PubMed 16005527

Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM (2005)
[Optic neuritis--diagnosis, treatment and follow up]
125 (4), 425-8 (Retracted)
PubMed 15742012

Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM (2005)
[Retraction of article]
125 (15), 2056
PubMed 16208878

Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS et al. (2005)
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
64 (7), 1144-51
DOI 10.1212/01.WNL.0000156155.19270.F8, PubMed 15824338

Publications 2004

Celius EG (2004)
Å leve med MS
Biogen IDEC Norge, Oslo, 31 s.
BIBSYS 041575970

Celius EG (2004)
Hva er MS?
Biogen Idec, Oslo (Oppdatert juni 2004), 38 s.
BIBSYS 061633496

Celius EG (2004)
Psykologi og MS
Biogen Idec, Oslo (Oppdatert juni 2004), 38 s.
BIBSYS 06163350x

Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A (2004)
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
63 (3), 237-47
DOI 10.1111/j.0001-2815.2004.00173.x, PubMed 14989713

Landrø NI, Celius EG, Sletvold H (2004)
Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS)
217 (2), 211-6
DOI 10.1016/j.jns.2003.10.012, PubMed 14706226

Oturai AB, Ryder LP, Fredrikson S, Myhr KM, Celius EG, Harbo HF, Andersen O, Akesson E, Hillert J, Madsen HO, Nyland H, Spurkland A, Datta P, Svejgaard A, Sorensen PS (2004)
Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs
10 (1), 5-8
DOI 10.1191/1352458504ms975oa, PubMed 14760946

Publications 2003

Bølviken B, Celius EG, Nilsen R, Strand T (2003)
Radon: a possible risk factor in multiple sclerosis
22 (1), 87-94
DOI 10.1159/000067102, PubMed 12566959

Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A (2003)
Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
143 (1-2), 101-6
DOI 10.1016/j.jneuroim.2003.08.021, PubMed 14575924

Lerdal A, Celius EG, Moum T (2003)
Fatigue and its association with sociodemographic variables among multiple sclerosis patients
9 (5), 509-14
DOI 10.1191/1352458503ms943oa, PubMed 14582778

Midgard R, Beiske AG, Celius EG, Jensen D, Hovdal H, Mellgren SI, Myhr KM (2003)
[New diagnostic criteria in multiple sclerosis]
123 (10), 1345-8
PubMed 12806674

Publications 2001

Celius EG, Vandvik B (2001)
Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period
8 (5), 463-9
DOI 10.1046/j.1468-1331.2001.00269.x, PubMed 11554910

Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A (2001)
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis
2 (5), 263-8
DOI 10.1038/sj.gene.6363774, PubMed 11528519

Publications 2000

Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A (2000)
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
178 (2), 132-5
DOI 10.1016/s0022-510x(00)00389-0, PubMed 11018705

Landrø NI, Sletvold H, Celius EG (2000)
Memory functioning and emotional changes in early phase multiple sclerosis
15 (1), 37-46
PubMed 14590566

Publications 1999

Celius EG (1999)
Hva er MS?
Ariez Pharma Consultancy, Amsterdam, 38 s.
BIBSYS 011580623

Celius EG (1999)
Psykologi og MS
Ariez Pharma Consultancy, Amsterdam, 38 s.
BIBSYS 020852878

Celius EG (1999)
Å leve med MS
Biogen, Amsterdam], 28 s.
BIBSYS 020853440

Harbo HF, Celius EG, Vartdal F, Spurkland A (1999)
CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
53 (1), 106-10
DOI 10.1034/j.1399-0039.1999.530112.x, PubMed 10082437

Myhr KM, Riise T, Green Lilleås FE, Beiske TG, Celius EG, Edland A, Jensen D, Larsen JP, Nilsen R, Nortvedt MW, Smievoll AI, Vedeler C, Nyland HI (1999)
Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis
52 (5), 1049-56
DOI 10.1212/wnl.52.5.1049, PubMed 10102427

Publications 1998

Brekke M, Hjortdahl P, Thelle DS, Celius EG, Heldal E, Joner G, Kvien TK (1998)
[Differences in morbidity between the Eastern central city district and the suburban Western district of Oslo]
118 (1), 14-7
PubMed 9481903

Publications 1997

Celius EG (1997)
[Neurologic complications in heroin abuse. Illustrated by two unusual cases]
117 (3), 356-7
PubMed 9064856

Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F (1997)
The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer
50 (1), 15-22
DOI 10.1111/j.1399-0039.1997.tb02828.x, PubMed 9243750

Publications 1996

Celius EG, Andersson S (1996)
Leucoencephalopathy after inhalation of heroin: a case report
60 (6), 694-5
DOI 10.1136/jnnp.60.6.694, PubMed 8648344